Filing Details
- Accession Number:
- 0001022079-18-000133
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-29 16:37:26
- Reporting Period:
- 2018-05-25
- Accepted Time:
- 2018-05-29 16:37:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1022079 | Quest Diagnostics Inc | DGX | Services-Medical Laboratories (8071) | 161387862 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1505998 | Mark Guinan | 500 Plaza Drive Secaucus NJ 07094 | Executive Vice President & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-05-25 | 61,533 | $58.37 | 119,733 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-05-25 | 36,573 | $105.42 | 83,160 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-05-25 | 24,960 | $106.14 | 58,200 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2018-05-25 | 61,533 | $58.37 | 61,533 | $58.37 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2023-08-19 | No | 4 | M | Direct |
Footnotes
- This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 22, 2018.
- This transaction was executed in multiple trades at prices ranging from $105.00 to $105.98. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $106.00 to $106.62. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The options vested in three equal annual installments beginning with the first on August 19, 2014, the second on August 19, 2015 and the final on August 19, 2016.
Billionaire Hedge Funds
